1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPostdoctoral Fellowship Program (BrightFocus Foundation) is sponsored by BrightFocus Foundation. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Apply for a Research Grant | BrightFocus Foundation Apply for a Research Grant BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of Alzheimer’s disease, macular degeneration, and glaucoma.
Alzheimer’s Disease Research Request for Proposals → Macular Degeneration Research Request for Proposals → National Glaucoma Research Request for Proposals → To start a new application and upload attachments, you must use our ProposalCentral application portal to apply online. Note: Your organization must be registered with ProposalCentral to apply.
Macular Degeneration Research grant recipient, Yong-Su Kwon, PhD It is our firm belief that having the courage to invest in innovative ideas will lead to revolutionary therapies. BrightFocus provides initial funding for highly innovative experimental ideas, including interdisciplinary investigations that may apply to two or three of the BrightFocus disease interests.
Most of the awardees use the BrightFocus award funds to demonstrate key findings that lead to later interest and additional funding from industrial or governmental funding agencies. Grant Application Resources Frequently Asked Questions Get answers to applicants’ frequently asked questions, from eligibility to the review process, categorized by each disease program.
From file type and size to formatting requirements, ensure your application checks the necessary boxes. Your guide to understanding the conditions of funding and the definitions and abbreviations used throughout the grant agreement. National Glaucoma Research-funded scientist Ignacio Provencio, PhD.
Recent News & Breakthroughs Browse research news and breakthroughs from BrightFocus-funded scientists. BrightFocus Journal Rises to Top 5 Neuroscience Journals Worldwide With a 2025 impact factor of 19. 6 and a No. 5 ranking among 330 neuroscience journals worldwide, Molecular Neurodegeneration continues to expand its influence on research into Alzheimer’s disease, macular degeneration, glaucoma, and related neurodegenerative disorders.
Breaking News Dispatch: Diversifying the Alzheimer’s Disease Treatment Portfolio Read the latest research news and findings from the latest international Alzheimer’s conference. Leqembi At-Home Injectable Now FDA Approved for Starting Alzheimer’s Treatment The FDA has extended approval for the at-home formulation of Leqembi to include starter, in addition to maintenance, doses, making treatment more accessible.
BrightFocus Foundation, Alzheimer’s LA Fund New AI-Driven Alzheimer’s Research Early-stage pilot grants aim to accelerate innovation and collaboration in Southern California.
BrightFocus Foundation Launches “Let’s Talk Alzheimer’s” Podcast Featuring Top Experts in Alzheimer’s Research New podcast features world-class scientists and doctors discussing late-breaking Alzheimer’s and dementia research in plain language for families and caregivers.
Lessons from Zebrafish: Restoring “Ground Zero” in Macular Degeneration BrightFocus Macular Degeneration Research grant recipient Lyndsay Leach, PhD, is investigating what makes another species capable of regrowing the part of the eye where age-related macular degeneration starts.
BrightFocus Foundation Announces President and CEO Planned Retirement and Launches National Search BrightFocus Foundation today announced that Stacy Pagos Haller has shared her intention to retire as president and chief executive officer following the successful completion of a national search and the appointment of a successor, after 16 years of leadership.
Understanding the Causes of Steroid-Induced Glaucoma A commonly used medication is linked to increased risk of glaucoma. A BrightFocus National Glaucoma Research-funded scientist is trying to understand why. Can Better Sleep Slow Alzheimer’s?
New BrightFocus-funded research suggests restoring sleep may help protect the brain from dementia progression, and a common insomnia drug could help lead the way. BrightFocus Journal Rises to Top 5 Neuroscience Journals Worldwide With a 2025 impact factor of 19.
6 and a No. 5 ranking among 330 neuroscience journals worldwide, Molecular Neurodegeneration continues to expand its influence on research into Alzheimer’s disease, macular degeneration, glaucoma, and related neurodegenerative disorders. Breaking News Dispatch: Diversifying the Alzheimer’s Disease Treatment Portfolio Read the latest research news and findings from the latest international Alzheimer’s conference.
Leqembi At-Home Injectable Now FDA Approved for Starting Alzheimer’s Treatment The FDA has extended approval for the at-home formulation of Leqembi to include starter, in addition to maintenance, doses, making treatment more accessible. BrightFocus Foundation, Alzheimer’s LA Fund New AI-Driven Alzheimer’s Research Early-stage pilot grants aim to accelerate innovation and collaboration in Southern California.
BrightFocus Foundation Launches “Let’s Talk Alzheimer’s” Podcast Featuring Top Experts in Alzheimer’s Research New podcast features world-class scientists and doctors discussing late-breaking Alzheimer’s and dementia research in plain language for families and caregivers.
Lessons from Zebrafish: Restoring “Ground Zero” in Macular Degeneration BrightFocus Macular Degeneration Research grant recipient Lyndsay Leach, PhD, is investigating what makes another species capable of regrowing the part of the eye where age-related macular degeneration starts.
BrightFocus Foundation Announces President and CEO Planned Retirement and Launches National Search BrightFocus Foundation today announced that Stacy Pagos Haller has shared her intention to retire as president and chief executive officer following the successful completion of a national search and the appointment of a successor, after 16 years of leadership.
Understanding the Causes of Steroid-Induced Glaucoma A commonly used medication is linked to increased risk of glaucoma. A BrightFocus National Glaucoma Research-funded scientist is trying to understand why. Can Better Sleep Slow Alzheimer’s?
New BrightFocus-funded research suggests restoring sleep may help protect the brain from dementia progression, and a common insomnia drug could help lead the way.
According to the current listing, eligibility includes: Young postdoctoral researchers conducting studies in an established laboratory focused on research contributing to understanding the biological causes and/or new clinical treatment of macular degeneration. Confirm the full requirements in the official notice before applying.
The current listing shows $100,000 per year for two years ($200,000 total). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Postdoctoral Fellowship Program (BrightFocus Foundation) is funded by BrightFocus Foundation. Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.